Antunes Humberto Calheiros 4

What Happened

• Humberto Calheiros Antunes, a director of Lifecore Biomedical, Inc. (LFCR), was granted 25,907 restricted stock units (RSUs) on 2026-06-04. The award is reported as an "A" (award/grant) on the Form 4; no purchase price or immediate cash value is provided. Per the filing, each RSU converts into one share of common stock on a 1:1 basis when settled.

Key Details

• Transaction date: 2026-06-04; Form 4 filed 2026-06-05 (timely filing).
• Transaction type/code: Award/Grant (A) of 25,907 RSUs; price: N/A; total dollar value: not reported in the filing.
• Vesting: RSUs vest on the earlier of June 4, 2027 or the date of the company’s 2027 annual meeting of stockholders, provided that meeting is at least 50 weeks after June 4, 2026 (per footnote).
• Shares owned after transaction: not specified in the provided summary.
• Footnotes: F1 confirms 1:1 conversion of RSUs to common stock; F2 describes the vesting condition above.

Context

• This grant is a compensation award, common for directors, and does not represent an open-market purchase or immediate sale. RSUs typically vest over time (here roughly one year) and align the director’s interests with shareholders once shares are issued. Because no per-share price or fair-market value is listed in the filing, investors should check LFCR’s prevailing share price around the grant date to estimate the award’s current market value.